Research and Development

Showing 15 posts of 9612 posts found.

EU image

The EU Falsified Medicines Directive: what does pharma need patients to know?

May 18, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing eu falsified, waarde

Recent legislation assumes that visual information can have direct effects on people’s behaviour. It starts from the assumption that a …
jenny_szkolar

Virgo Health Education announces new senior team

May 15, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Virgo Health Education

Virgo Health Education has appointed a new head of medical education and announced a number of senior team promotions.  Katherine …
len_hedge

OrthoAccel Technologies appoints new board member

May 14, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing OrthoAccel Technologies, len hedge

US-based medical device firm OrthoAccel Technologies has announced that Len Hedge has joined its board of directors.  Hedge currently serves on the …
Astrazeneca image

AstraZeneca makes a move into precision medicine

May 13, 2015 Research and Development, Sales and Marketing AstraZeneca, Precision Medicine, cardiovascular diseases, diabetes, mhi

AstraZeneca has signalled its intention to ramp up the use of personalised medicine strategies to find new candidate drugs and …

Baxter buys cancer portfolio for $900 million

May 13, 2015 Research and Development, Sales and Marketing Cancer, Oncaspar, Sigma-Tau Finanziaria, baxter, oncology

Baxter is buying leukaemia treatment Oncaspar from Italian firm Sigma-Tau Finanziaria for $900 million as the US firm looks to …
erwin_estigarribia

Applied Proteomics hires commercial VP

May 13, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Applied Proteomics, Erwin Estigarribia

San Diego’s Applied Proteomics that develops protein-based molecular diagnostics has confirmed the appointment of Erwin Estigarribia as the VP of …
ASCO image

Pharma reveals its ASCO presentation data

May 12, 2015 Research and Development, Sales and Marketing ASCO, AZ, AbbVie, Roche, chicago, data

AstraZeneca, Genentech and AbbVie have all revealed which cancer drugs they will show data for at The American Society of …
jeff_poulton_shire

New chief financial officer for Shire

May 12, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, jeff poulton

Irish pharma firm Shire has appointed a new chief financial officer and member of its executive committee in Jeff Poulton. …
Takeda image

Takeda announces new cancer collaboration

May 11, 2015 Research and Development, Sales and Marketing Cancer, Europe, Takeda, mental health, ncc

Takeda will be teaming up with Japan’s National Cancer Center (NCC) to develop new cancer drugs. The two organisations have …
GSK image

GSK launches new HIV research centre

May 11, 2015 Research and Development, Sales and Marketing AIDS, GSK, HIV, UNC-Chapel Hill, ViiV, qura

GlaxoSmithKline is boosting its philanthropic efforts in R&D into HIV/AIDS by teaming up with academic researchers to launch a new …
harvey_berger

Ariad founder retires

May 11, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ariad, harvey Berger

Dr Harvey Berger the founder of US pharma firm Ariad Pharmaceuticals has announced his decision to retire as chairman and …
ViiV founder Dr Manuel Goncalves

Reputation gains from focussing on the patient

May 11, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, HIV, Manuel Goncalves, Pfizer, ViiV

Since being spun-off from GSK and Pfizer, specialist HIV firm ViiV Healthcare has earned the best corporate reputation amongst patients …
Vaccine image

New malaria vaccine found effective in adults

May 8, 2015 Research and Development, Sales and Marketing Oxford, Plasmodium falciparum, Vaccine, malaria

A new malaria vaccine has shown promise in early stage trials, reducing the risk of contracting the disease by two …
tom_richards

Havas Lynx Group hires three

May 8, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HAVAS LYNX, bainton, linscott, richards

Havas Lynx Group has just bolstered its ranks with the arrival of three new senior appointments. Jon Linscott joins Tim …

Alexion makes $8.4 billion Synageva purchase

May 7, 2015 Research and Development, Sales and Marketing Alexion, Shire, nps, rare disease, synageva

Rare disease specialist firm Alexion is splashing out $8.4 billion to buy fellow US orphan drug developer Synageva biopharmaceuticals. The …
The Gateway to Local Adoption Series

Latest content